Hydrocodone products are now Schedule II Controlled Substances
Hydrocodone Combination Products (HCPs) have been moved from Schedule III to the more-restrictive Schedule II, effective Oct. 6, 2014. The U.S. Drug Enforcement Administration’s rescheduling of HCPs as a Schedule II Controlled Substance will increase restriction on prescribing and dispensing practices for HCPs. See Hydrocodone: Schedule II Controlled Substance for more information.
Notice to physicians licensed by the Texas Medical Board (TMB) under Texas Occupations Code, Chapter 156:
To continue implementing requirements of House Bill 1803, DPS is beginning the process to synchronize Controlled Substances Registration (CSR) expiration dates with TMB license expiration dates. To ensure practitioners do not experience disruption in their controlled substances authority, the following has occurred:
Physicians whose CSR is scheduled to expire in the months of July through December 2014:
Please continue to visit this webpage for updates and additional information about synchronization of CSRs to expire on future dates.
NOTE: This information applies to those physicians (MD/DO) who hold a registration permit issued by the TMB under Texas Occupations Code, Chapter 156.